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Abstract
Background: Proper control of cerebrovascular risk is essential to prevent cognitive change in dementia due to Alzheimer’s disease (AD). Objective: To 
investigate whether caregiver awareness to control cerebrovascular risk impacts the lifestyles of patients with AD. Methods: Consecutive outpatients with AD 
were assessed for demographic features, Clinical Dementia Rating scores, cerebrovascular risk, pharmacotherapy, dietary therapy and practice of physical 
activities. Patients and caregivers were inquired on awareness of the importance of measures to control cerebrovascular risk. Chi-square test was employed 
for statistics, significance at ρ < 0.05. Results: A total of 217 patients were included; whereas 149 caregivers (68.7%) were aware of the need to control ce-
rebrovascular risk, only 11 patients (5.1%) simultaneously practiced physical activities and received pharmacological treatment and dietary therapy. Patients 
with hypertension and diabetes mellitus were more likely to receive dietary therapy (ρ = 0.007). Male patients were more engaged in physical activities (ρ = 
0.018). Patients in earlier AD stages exercised (ρ = 0.0003) and received pharmacological treatment more often (ρ = 0.0072). Caregiver awareness of the need 
to control cerebrovascular risk was higher when patients had hypertension (ρ = 0.024) and/or hypercholesterolemia (ρ = 0.006), and influenced adherence 
to dietary therapy (ρ = 0.002) and to pharmacological treatment (ρ = 0.001). Discussion: Caregiver awareness of the need to control cerebrovascular risk has 
positive impacts for patients with AD.
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Resumo 
Contexto: O risco cerebrovascular é fundamental na etiologia da demência da doença de Alzheimer (DA), sendo importante seu controle adequado. Objetivo: 
Investigar se o conhecimento dos cuidadores sobre o controle do risco cerebrovascular tem impacto sobre a saúde de pacientes com DA. Métodos: Pacientes 
consecutivos com DA foram avaliados quanto a dados demográficos, Clinical Dementia Rating, risco cerebrovascular, tratamento farmacológico, dietoterapia 
e prática de atividades físicas. Pacientes e cuidadores foram questionados quanto à importância de medidas para controle do risco cerebrovascular. Chi-qua-
drado foi empregado na análise estatística, significância com ρ < 0,05. Resultados: No total, 217 pacientes foram incluídos; enquanto 149 cuidadores (68,7%) 
conheciam a necessidade de controle do risco cerebrovascular, somente 11 pacientes (5,1%) simultaneamente praticavam exercícios e recebiam tratamento 
farmacológico e dietoterápico. Pacientes com hipertensão arterial e diabetes mellitus tinham maiores chances de receber dietotetapia (ρ = 0,007). Homens 
estavam mais engajados em atividades físicas (ρ = 0,018). Pacientes em estágios precoces da DA praticavam exercícios (ρ = 0,0003) e recebiam farmacotera-
pia mais frequentemente (ρ = 0,0072). O conhecimento dos cuidadores acerca do controle do risco cerebrovascular era maior quando os pacientes tinham 
hipertensão arterial (ρ = 0,024) e/ou dislipidemia (ρ = 0,006), e influenciou a adesão à dietoterapia (ρ = 0,002) e à farmacoterapia (ρ = 0,001). Conclusão: O 
conhecimento dos cuidadores acerca do risco cerebrovascular tem impactos positivos para pacientes com DA.
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Introduction
It has been demonstrated that cerebrovascular risk factors influence 
the incidence of mild cognitive impairment1 and its rate of progres-
sion to dementia due to Alzheimer’s disease1,2. Caregivers have an 
important role in the control of cerebrovascular risk of patients with 
dementia.
A longitudinal Brazilian study3 previously described that a 
decline in the degree of awareness of Alzheimer’s disease follows 
depressive symptoms, cognitive and functional decline. Awareness of 
the dementia syndrome may be important for its proper treatment; 
nevertheless, no studies have ever evaluated the impact of awareness 
of cerebrovascular risk factors over measures to control them.
An earlier preliminary study4 confirmed that patients were more 
likely to accept pharmacological therapy or to follow a diet when 
caregivers were aware of the importance to control cerebrovascular 
risk, and also that patients who followed a diet were more likely to 
practice physical activities or to accept pharmacological therapy. In 
the present study, with a more comprehensive evaluation of a larger 
sample, we sought to investigate whether caregiver awareness to con-
trol cerebrovascular risk has any impact on the lifestyles of patients 
with dementia due to Alzheimer’s disease, as well as to describe any 
relations between the presence of cerebrovascular risk factors and 
adherence to dietary therapy or regular practice of physical activities.
Methods
Consecutive outpatients with dementia due to Alzheimer’s disease 
in different stages were recruited from November 2010 to February 
2013 (28 months) at the Behavioral Neurology Section of Hospital São 
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Paulo. After diagnostic confirmation, they were assessed for: gender, 
schooling, estimated age of onset of dementia due to Alzheimer’s 
disease, estimated length of the dementia syndrome, Clinical Demen-
tia Rating5 (CDR) scores, marital status, urban living (considering 
patients who lived in non-rural settings for at least two thirds of their 
lifetimes), sanitation (considering patients who lived in environ-
ments with sanitation for at least two thirds of their lifetimes), body 
mass index, arterial hypertension, hypercholesterolemia, diabetes 
mellitus, dietary therapy, pharmacological therapy, regular practice 
of physical activities, family history of Alzheimer’s disease or other 
neuropsychiatric disorders, family history of cardiovascular diseases, 
and quantification of alcohol consumption or smoking. Family his-
tory of neuropsychiatric disorders included only those with non-
infectious and non-vascular causes (cerebrovascular diseases were 
included as family history of cardiovascular diseases), and family 
history of cardiovascular diseases did not include infectious causes 
such as Chagas’ disease. Patients and caregivers were inquired on 
awareness of the importance to control cerebrovascular risk factors. 
The expected answer was that such control would be important for 
prevention of vascular events or neurodegenerative diseases such as 
Alzheimer’s disease. Caregivers were also inquired whether patients 
were encouraged to follow any specific diets, to regularly practice any 
physical activities, or to accept pharmacological treatment. All body 
mass index measurements and caregiver assessments were conducted 
on weekdays at morning time, by the same examiner (FFO).
Diagnosis of dementia due to Alzheimer’s disease was in accor-
dance with National Institute on Aging – Alzheimer’s Association 
criteria6. Obesity was diagnosed when body mass index was over 
30 kg/m2.
For statistical analysis, lifetime drinking in excess of ten liters per 
year of alcoholic beverages was considered. Lifetime smoking in any 
quantity was weighted in the analysis. Diagnosis of arterial hyperten-
sion was in accordance with the JNC 7 Report7, diagnosis of diabetes 
mellitus was in accordance with American Diabetes Association 
criteria8, and diagnosis of hypercholesterolemia was in accordance 
with the third report of the National Cholesterol Education Program9.
Physical activities were considered if they were non-work related, 
of at least moderate intensity (≥ 3 METS), comprising equivalents 
to walking or running summing up to at least one km per week, or 
engaging in other physical activities summing up to at least one hour 
per week. Any activities in lesser intensity were taken as physical 
inactivity.
Statistical comparisons for all groups were conducted by way 
of Chi-square test. The threshold of significance was set at ρ < 0.05.
This study is part of the research project 1067/10 (CAAE 
0540.0.174.000-10) approved by the Ethics Committee of Hospital 
São Paulo on August 2010. All patients and their legal representatives 
signed the Informed Consent Form before the evaluation. All invited 
patients and their respective caregivers agreed to participate on the 
research, with no exceptions.
Results
A total of 217 patients were included, and none were excluded; 147 
were female (67.7%) and 70 were male (32.3%); 109 (50.23%) were 
married, while six (2.76%) were divorced, 19 (8.76%) were single, and 
83 (38.25%) were widowers; 56 (25.8%) had history of alcohol use, 
whereas 11 (5.1%) were regularly drinking at survey time; 79 (36.4%) 
had smoking history, whereas 14 (6.5%) were regular smokers at 
survey time. All patients lived in urban environments at evaluation 
time. Obesity was diagnosed in 36 patients (16.6%). Table 1 shows 
full demographic data of patients.
Among female patients, 43 (29.3%) followed a diet, ten (6.8%) 
regularly practiced physical activities, and 103 (70.1%) received phar-
macological treatment. Among male patients, 23 (32.9%) followed a 
diet, 12 (17.1%) regularly practiced physical activities, and 51 (72.9%) 
received pharmacological treatment. No impact of gender was found 
over adherence to dietary therapy (ρ = 0.589) or to pharmacological 
therapy (ρ = 0.672), but male patients were significantly more engaged 
Table 1. Demographic data of patients
Variable (units), n = 217 Mean SD* Range
Age of dementia onset (years-old) 73.19 6.8 52-88
Length of the dementia syndrome (years) 5.4 2.9 0.5-14.5
Schooling (years) 4.21 3.7 0-15
Body mass index (kg/m2) 25.75 4.3 14.28-41.62
Lifetime alcoholic drinking load (liters per year) 17.26 50.8 0-315
Current alcoholic drinking load (liters per year) 1.67 11.3 0-120
Lifetime smoking load (packs per year) 48.75 103.7 0-700
Current smoking load (packs per year) 14.38 62.1 0-365
* SD: standard deviation.
in physical activities than female patients (ρ = 0.018). Nonetheless, 
patient gender had no impact over caregiver awareness of the need 
to control cerebrovascular risk (ρ = 0.984).
Regarding CDR scores, 83 patients (38.3%) scored 1.0, 104 pa-
tients (47.9%) scored 2.0, and 30 patients (13.8%) scored 3.0. Among 
mildly impaired patients (CDR = 1.0), 31 (37.3%) followed a diet, 
17 (20.5%) regularly practiced physical activities, and 69 (83.1%) 
received pharmacological treatment. Among moderately impaired 
patients (CDR = 2.0), 28 (26.9%) followed a diet, five (4.8%) regularly 
practiced physical activities, and 67 (64.4%) received pharmacologi-
cal treatment. Among severely impaired patients (CDR = 3.0), seven 
(23.3%) followed a diet, none were regularly practicing physical 
activities, and 18 (60.0%) received pharmacological treatment. No 
impact of CDR scores over dietary therapy was found (ρ = 0.202), but 
patients in the earlier dementia stages would significantly practice 
more physical activities (ρ = 0.0003) and be more prone to receive 
pharmacological therapy (ρ = 0.0072). Nevertheless, CDR scores had 
no impact over caregiver awareness of the need to control cerebro-
vascular risk (ρ = 0.984).
Table 2 shows relationships between awareness of the need to 
control cerebrovascular risk and assessed variables. Overall 119 
patients (54.8%) had family history neither of Alzheimer’s disease 
nor of other neuropsychiatric syndromes, but 77 patients reported 
family history of Alzheimer’s disease, and 27 reported family history 
of other neuropsychiatric disorders (sometimes more than once in 
the same family): nine relatives with epilepsy (eight with onset during 
childhood), six with parkinsonian syndromes, six with schizophrenia, 
six with bipolar disorder, three with brain cancer, one cousin with 
amyotrophic lateral sclerosis, and one daughter with writer’s cramp.
Table 3 shows relationships between cerebrovascular risk and 
adherence to dietary therapy. Table 4 shows relationships between 
cerebrovascular risk and regular practice of physical activities.
Only 11 (5.1%) of the 217 patients were under pharmacological 
therapy and reported following a diet and regularly practicing physi-
cal activities at the same time. Among the 63 patients who reported no 
pharmacological therapy for control of cerebrovascular risk, ten had 
neither hypertension nor diabetes mellitus nor hypercholesterolemia.
Discussion
Considering the modest effects of cholinesterase inhibitors and me-
mantine over cognition and functionality of patients with dementia 
due to Alzheimer’s disease10, control of modifiable risk factors is a 
major therapeutic goal11. More than a third of worldwide cases of 
Alzheimer’s disease are attributable to cerebrovascular risk factors12. 
While the burden of dementia is recognizable all around the world, 
its prevalence seems to be higher in Europe and North America11, 
rather than in Latin America, Africa, India or China. Prevalence 
of dementia due to Alzheimer’s disease in people over 65 years-old 
may vary from 1.3% in India to 2.7% in Brazil, reaching up to 20.5% 
in Israel (where consanguinity among families is common)13; how-
ever, these results might be biased by the employment of different 
diagnostic criteria13,14 or less access to tertiary health care in poorer 
countries of the southern hemisphere.
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Table 2. Relationships between awareness of the need to control cerebrovascular risk and variables of interest
Assessed variables of patients (n = 217) n %
Patients’ and/or caregivers’ awareness of the need to control 
cerebrovascular risk









Urban living† 189 87.1 130 19 59 9 0.921
Sanitation‡ 190 87.6 133 16 57 11 0.260
Arterial hypertension 173 79.7 125 24 48 20 0.024
Hypercholesterolemia 166 76.5 122 27 44 24 0.006
Diabetes mellitus 56 25.8 44 105 12 56 0.063
Obesity 36 16.6 27 122 9 59 0.369
Lifetime alcohol consumption§ 38 17.5 25 124 13 55 0.674
Lifetime smoking 79 36.4 51 98 28 40 0.324
Dietary therapy 66 30.4 55 94 11 57 0.002
Physical activities 22 10.1 18 131 4 64 0.161
Pharmacological therapy 154 70.9 116 33 38 30 0.001
Family history of Alzheimer’s disease 77 35.5 58 91 19 49 0.117
Family history of other neuropsychiatric disorders 27 12.4 17 132 10 58 0.495
Family history of cardiovascular diseases 74 34.1 54 95 20 48 0.325
* Chi-square test.
† Patients who lived in urban (non-rural) environments for at least two thirds of their lifetimes.
‡ Patients who lived in environments with sanitation for at least two thirds of their lifetimes.
§ More than ten liters of alcoholic beverages per year.
Table 3. Relationships between cerebrovascular risk and adherence to dietary therapy
Variables of cerebrovascular risk or pharmacological 
treatment of patients
Dietary therapy
ρ-value*YES (n = 66) NO (n = 151)
Variable present Variable absent Variable present Variable absent
Arterial hypertension 60 6 113 38 0.007
Hypercholesterolemia 55 11 111 40 0.116
Diabetes mellitus 25 41 31 120 0.007
Obesity 11 55 25 126 0.984
Physical inactivity 55 11 140 11 0.035
Pharmacological therapy 63 3 91 60 < 0.001
* Chi-square test.
Table 4. Relationships between cerebrovascular risk and regular practice of physical activities
Variables of cerebrovascular risk or pharmacological 
treatment of patients
Regular physical activities
ρ-value*YES (n = 22) NO (n = 195)
Variable present Variable absent Variable present Variable absent
Arterial hypertension 20 2 153 42 0.169
Hypercholesterolemia 19 3 147 48 0.250
Diabetes mellitus 5 17 51 144 0.728
Obesity 2 20 34 161 0.319
Dietary therapy 11 11 55 140 0.035
Pharmacological therapy 20 2 134 61 0.030
* Chi-square test.
This sample consisted mostly of patients who were born in the 
first half of the last century, with low access to formal education, 
and who were more prone to pharmacological treatment of their 
comorbidities than to dietary therapy or regular physical activities. 
More than 80% of the patients who did not receive pharmacological 
treatment had at least one uncontrolled cerebrovascular risk factor, 
an information that reflects the need for more patient education with 
regard to public health policies, even in the largest city in Brazil.
Even though urban living with sanitation was the rule for most 
patients, it should be considered that this is a sample with access to 
treatment in an university hospital, and probably does not reflect 
what happens in the whole country. Considering that recruitment 
was carried out in a single center, results may not be generalizable 
to the whole population of São Paulo. Nevertheless, urban living and 
sanitation did not impact awareness of cerebrovascular risk.
Caregiver awareness of the need to control cerebrovascular 
risk was significantly higher when patients had arterial hyperten-
sion and/or hypercholesterolemia, and had significant impacts 
over adherence to dietary therapy and to pharmacological treat-
ment. A marginally significant association was also found for 
such awareness when patients had diabetes mellitus, but not when 
patients regularly practiced physical activities, a fact that could be 
a result of overall low adherence to such activities for control of 
cerebrovascular risk.
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There is evidence that anti-oxidants15, polyunsaturated fatty acids 
(particularly present in fish oil) and a Mediterranean diet can reduce 
cognitive decline15,16, while dietary therapy is a major component of 
the control of cerebrovascular risk. Caregivers of patients with heart 
failure have reported that the most burdensome aspects of care are 
enforcing dietary restriction and adherence17. Almost 70% of our 
patients did not follow specific dietary patterns. Patients who received 
dietary therapy were more likely to also receive pharmacological 
treatment and to regularly practice physical activities. Patients with 
arterial hypertension and diabetes mellitus were significantly more 
likely to receive dietary therapy.
Midlife obesity is known to be a risk factor for dementia due to 
Alzheimer’s disease, particularly when associated with other cerebro-
vascular risk factors18; on the other hand, weight loss may be an early 
symptom of dementia, but patients are expected to lose more weight 
in later dementia stages18,19. In late life, hyperleptinemia as a result 
of obesity may be protective against cognitive decline18, and it has 
been shown that oral nutritional supplementation is more effective 
compared to nutrition education in improving the nutritional status 
of patients with dementia due to Alzheimer’s disease19. Nevertheless, 
we found no relation of obesity with awareness of cerebrovascular risk 
or adherence to dietary therapy or physical activities in this sample.
Long-term regular physical activity is associated with positive 
behavior20, higher levels of cognitive function and less cognitive 
decline16,20, particularly in patients with dementia15, while increasing 
brain neurotrophins, perfusion and plasticity16,21. Elderly with dis-
abilities usually have lower levels of participation in social activities, 
but their social engagement tends to be more strongly related to life 
satisfaction22. Exercise reduces the risks of developing both mild 
cognitive impairment and dementia23,24. However, no association has 
been found so far between physical activity and Alzheimer’s disease 
biomarkers25. Little more than 10% of our patients reported regular 
practice of physical activities, even if we consider the flexible criteria 
employed for such assessment. Patients who regularly practiced 
physical activities were more likely to receive dietary therapy and/
or pharmacological treatment, while isolated cerebrovascular risk 
factors such as arterial hypertension, hypercholesterolemia, diabetes 
mellitus and obesity had no significant impacts over engagement in 
physical activities.
No gender differences were found with regard to adherence to 
dietary therapy or to pharmacological treatment, but male patients 
were significantly more likely to regularly practice physical activities 
than female patients, regardless of caregiver awareness of the need 
to control cerebrovascular risk. This is an unfortunate result, in view 
of the fact that rates of arterial hypertension, hypercholesterolemia 
and diabetes mellitus are higher in elderly women than in similarly 
aged men26.
With progression of cognitive decline, patients would signifi-
cantly practice less physical activities and be less prone to receive 
pharmacological treatment, regardless of caregiver awareness of the 
need to control cerebrovascular risk. No severely impaired patients 
would regularly practice physical activities. In spite of the cognitive 
decline, low caregiver motivation might have been an important ele-
ment for physical inactivity. A non-significant trend was also found 
for more severely impaired patients to not receive dietary therapy.
Chronic caregiving stress is associated with increased cerebro-
vascular risk. Earlier reports have provided evidence that caregiver 
burden is associated with carotid artery intima-media thickness 
and impaired endothelial function27,28, particularly in the elderly, 
while chronically increasing serum levels of biomarkers of inflam-
mation such as C-reactive protein and tumor necrosis factor α29. A 
recent Brazilian study30 showed that caregivers have higher odds 
of negatively evaluating their physical health, disposition, mood, 
memory, and the capacity to perform leisure activities as compared 
with non-caregivers, reflecting poorly on their quality of life. Even 
though cerebrovascular risk of caregivers may influence the control 
of patients’ cerebrovascular risk factors, one of the weaknesses of our 
study is that vascular health of caregivers was not assessed.
A total of 149 caregivers (68.7%) reported full awareness of the 
need to control cerebrovascular risk, but less than 6% of our patients 
received pharmacological treatment while following a diet and regu-
larly practicing physical activities at the same time. It is possible that 
this is a result of low simultaneous engagement in all components of 
control of cerebrovascular risk rather than lack of education regard-
ing such measures, particularly considering that more than 70% 
of our patients received pharmacological treatment for control of 
their cerebrovascular risk factors. Anti-hypertensive treatment16,31, 
most importantly with angiotensin-converting enzyme inhibitors 
and diuretics31, is particularly helpful in slowing cognitive decline 
for patients with dementia independently of blood pressure control.
To the best of our knowledge, this is the first original study to ever 
demonstrate the impact of caregiver awareness of cerebrovascular 
risk over the lifestyles of patients with dementia due to Alzheimer’s 
disease. Regardless of the moderately large sample, its major limi-
tations reside in the self-reported dietary and exercise patterns as 
sole measures of intensity, while its cross-sectional nature does not 
allow for causal inferences. Considering that spousal caregivers may 
have higher cardiovascular risk and all-cause mortality due to high 
levels of strain17, further studies should also assess the impacts of 
cerebrovascular risk factors of patients over caregiver health. We 
conclude that public health policies should promote the knowledge 
that cerebrovascular risk is a major impact factor for the burden of 
dementia worldwide, and that control of cerebrovascular risk factors 
impacts both the incidence and the progression of dementia due to 
Alzheimer’s disease.
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